In the late 70’s, the discovery of the restriction enzymes made possible the biological production of functional proteins by recombinant DNA technologies, a fact that largely empowered both biotechnological and pharmaceutical industries. Short peptides or small protein domains, with specific molecular affinities, were developed as purification tags in downstream processes to separate the target protein from the culture media or cell debris, upon breaking the producing cells. Among these tags, and by exploiting the interactivity of the imidazole ring of histidine residues, the hexahistidine peptide (H6) became a gold standard. Although initially used almost exclusively in protein production, H6 and related His-rich peptides are progressively proving a broad applicability in novel utilities including enzymatic processes, advanced drug delivery systems and diagnosis, through a so far unsuspected adaptation of their binding capabilities. In this context, the coordination of histidine residues and metals confers intriguing functionalities to His-rich sequences useable in the forward-thinking design of protein-based nano- and micro-materials and devices, through strategies that are comprehensively presented here.

Original languageEnglish
Article number107817
Number of pages15
JournalBiotechnology Advances
Publication statusPublished - 1 Jan 2022


  • Biomaterials
  • Biosensing
  • Modular protein
  • Nanobiotechnology
  • Recombinant protein


Dive into the research topics of 'Insights on the emerging biotechnology of histidine-rich peptides'. Together they form a unique fingerprint.

Cite this